Adreview

Active Ingredient(s): Iobenguane I 123
FDA Approved: * September 19, 2008
Pharm Company: * GE HEALTHCARE
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Adreview Overview

Iobenguane, or MIBG, is an aralkylguanidine analog of the adrenergic neurotransmitter, typically used as a radiopharmaceutical.[1] It acts as a blocking agent for adrenergic neurons. When radiolabeled, it can be used in nuclear medicinal diagnostic and therapy techniques as well as in neuroendocrine chemotherapy treatments. It localizes to adrenergic tissue and thus can be used to identify the location of tumors such as pheochromocytomas and neuroblastomas.[2] ...

Read more Adreview Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Iobenguane

Recent Adreview Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Iobenguane I 123
  • Injection: 555mbq/ml(15mci/ml), 5ml
  • Solution: 10mci/5ml (2mci/ml), 15mci/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Adreview: (1 result)

Sorted by National Drug Code
  • 17156-235 Adreview 2 mci/Ml Intravenous Injection by Medi-physics Inc.

Other drugs which contain Iobenguane I 123 or a similar ingredient: (2 results)